Trials / No Longer Available
No Longer AvailableNCT02531672
Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography
Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography: An Expanded Access Study
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to use a new imaging drug called 11C-choline that is used with a PET/CT scan to see prostate cancer when it cannot be seen well on other scans, such as bone scans, CT or MRI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 11C-choline | |
| DEVICE | PET/CT Scan |
Timeline
- First posted
- 2015-08-24
- Last updated
- 2020-06-05
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02531672. Inclusion in this directory is not an endorsement.